CSL Limited
CSLBiotechnology
A$200.73+1.64%As of Oct 30vs prior close
- Market cap
- $67.7B
- P/E (TTM)
- –
- P/E (FY1)
- 22.8×
- From 52W high
- 0.00%
- EPS (TTM)
- –
- Revenue (LTM)
- $15.8B
- Net margin
- -16.33%
- Dividend yield
- 2.02%
Nomior Score
50
Steady ProfileBottom 50% of the scored universe
Growth46
Quality58
Value50
Momentum49
Resilience50
Growth
+8.22%revenue a year over 2 fiscal years
YE23 $13.2BLTM $15.8B
Connections
Revenue to profitYE25
19% of revenue became net profit, up 1 pt on a year.